Fundz
Free weekly newsletter

Get the free weekly executive digest

The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New leadership moves, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Leadership Trends

See who's moving and how much in your market

No credit card required Weekly executive digest

Oral Biolife Appoints Doug Nissinoff As Chief Business Officer

PRIVATEApr 11, 2024about 2 years ago

Position

Chief Business Officer

Company

Oral Biolife

Doug Nissinoff
BethlehemBiotechnologyHealth CareOther Investment Fund

Description

Oral Biolife has appointed Doug Nissinoff as its Chief Business Officer. Doug Nissinoff brings extensive experience in healthcare, finance, and venture capital with a proven track record of growth and strategic direction for numerous companies in the life sciences industry. His appointment as Chief Business Officer marks a major milestone for the company, paving the way for future innovation and expansion.

Company Information

Company

Oral Biolife

Location

Bethlehem, Pennsylvania, United States

About

OralBiolife is an innovative biotech company utilizing Piezo materials to develop a groundbreaking product, PiezoGEL (TM) for the treatment of periodontal disease. OralBiolife's In-vivo studies have demonstrated bone regeneration measuring the distance between the bone line and a tooth reference. Calculated as a ratio before/after treatment. The results are astounding! After one month of therapy, PiezoGEL (TM) showed a significant reduction in the exposed dental roots compared to the clinical standard. Our In-vivo data, demonstrates that PiezoGEL (TM) is a superior treatment for periodontitis because of its unique ability to inhibit the recolonization of biofilms and regenerative bone properties. Since PiezoGEL (TM) catalyzes bone regeneration and eliminates and prevents infection, it has a significant medical and commercial advantage over existing non-surgical treatments. OralBiolife has developed a Platform with this Technology: The bone-regenerating technology may be applied to many applications that require a sterile, high-quality seal with bone, including dental and orthopedic implants. The remineralization activity may also be applied to dental sealants and composite restorations.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Oral Biolife's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.